CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 24 enrolled
Drug / intervention
dian dao sandrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05045469
NCT05045469Phase 2Completed

Therapeutic Effects of Topical Herbal Medicine on Rosacea

Chang Gung Memorial Hospital·interventional·Posted Sep 16, 2021·Updated Apr 1, 2025

In Brief

A Phase 2 clinical trial evaluating dian dao san for Rosacea and Chinese Herbal Medicine. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The aim of this study is to investigate the effects of topical herbal medicine in the patients with rosacea.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesTaiwan
Collaborators--

Timeline

Phase 2CompletedFinished
20222023202420252026
First PostedSep 16, 2021
Enrollment StartAug 4, 2021
Primary CompletionMay 23, 2024
Study CompletionAug 4, 2024
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 4.8 years ago

Interventions

dian dao sandrug

dian dao san and placebo will be used in the rosacea lesions twice a day for 6 weeks